CD68 and COVID-19: Several studies have demonstrated that patients with severe COVID-19 have increased inflammatory monocyte and CD68+ macrophage infiltration and a corresponding decrease in anti-inflammatory alveolar macrophages (Wauters et al., 2021; Chen et al., 2022).